Morelli, F.; Matis, S.; Benelli, R.; Salvini, L.; Zocchi, M.R.; Poggi, A.
Antibody–Drug Conjugate Made of Zoledronic Acid and the Anti-CD30 Brentuximab–Vedotin Exert Anti-Lymphoma and Immunostimulating Effects. Cells 2024, 13, 862.
https://doi.org/10.3390/cells13100862
AMA Style
Morelli F, Matis S, Benelli R, Salvini L, Zocchi MR, Poggi A.
Antibody–Drug Conjugate Made of Zoledronic Acid and the Anti-CD30 Brentuximab–Vedotin Exert Anti-Lymphoma and Immunostimulating Effects. Cells. 2024; 13(10):862.
https://doi.org/10.3390/cells13100862
Chicago/Turabian Style
Morelli, Feliciana, Serena Matis, Roberto Benelli, Laura Salvini, Maria Raffaella Zocchi, and Alessandro Poggi.
2024. "Antibody–Drug Conjugate Made of Zoledronic Acid and the Anti-CD30 Brentuximab–Vedotin Exert Anti-Lymphoma and Immunostimulating Effects" Cells 13, no. 10: 862.
https://doi.org/10.3390/cells13100862
APA Style
Morelli, F., Matis, S., Benelli, R., Salvini, L., Zocchi, M. R., & Poggi, A.
(2024). Antibody–Drug Conjugate Made of Zoledronic Acid and the Anti-CD30 Brentuximab–Vedotin Exert Anti-Lymphoma and Immunostimulating Effects. Cells, 13(10), 862.
https://doi.org/10.3390/cells13100862